© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| EFFECT | EFFECT |
View HTML | |
| POS AM | Post-effective amendment to an S-Type filing |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 3 | Initial filing by director officer or owner of more than ten percent. |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 424B3 | Form of prospectus reflecting facts events constituting substantive change from last form |
View HTML | |
| SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML |
Data provided by Kaleidoscope.